Out-licensing: Diagnostic & Endocrinology/Growth Disorders

Latest: Watch here for details of new products and services.

About Us: Innovaro Pharmalicensing - Partnering solutions for the life sciences
Our Products: Overview; Partnering Search; Company Profiling; Pay-per-Click New!; Deal Negotiation; PL Intelligence; Reports; Comparison
PL Intelligence: Overview; Industry news; Deals review; Press releases; Articles
Case Studies: See what others think about our service
Newsletter: Partnering update; Key reports; Subscribe
Quick Links: Profile now; Register now; Profiled companies; Featured events; Industry news; PR Newswire; Jobs
Contact Innovaro Pharmalicensing: Send an email; Call us: +44 1904 520460; Request a callback
RSS Feeds: Keep up to date

Innovaro Pharmalicensing
is a division of
Innovaro Europe Ltd

Up-to-date access to technology licensing opportunities worldwide.

Displaying 1..10 of 43 - per page Next page
Order by

A Genetic Screen for Newborns: Fbxo11 as a Genetic Marker for Chronic Otitis Media (Glue Ear) More

Diagnosis of Smith-Lemli-Opitz Syndrome: A Novel Non-invasive Assay More

Improving Molecular Diagnostics for Galactosemia: Applicable to Universal Newborn Screening More

Novel Biomarkers for Detection of Early Onset Neonatal Sepsis (EONS) and other Complications of Prematurity More

Development of a Genetic Test for the Diagnosis of Carboxylesterase-1 Deficiency: Genetic Predisposition for ADHD More

Single Round PCR Assay to Detect Low Copy HIV-1 in Filter Paper Blood Spots More

Diagnosis of Rett Syndrome: Identification of Mutations in the Methyl-CpG-binding Domain More

Diagnostic Blood Test to Identify Newborns at Risk for Sepsis More

Invasive Trophoblast Antigen-2: A Biochemical Test for Identifying Pregnancies with Down Syndrome Foetus More

Development of a Non-invasive Diagnosis Test for Allograft Rejection More

Displaying 1..10 of 43 - per page Next page
Order by

Industry sector: Antibody-based diagnostics; Biomarker-based diagnostics; CAT; Genetic diagnostics; Imaging; MRI; Nuclear medicine; Other; Self-test systems; Supplies; Test systems; Ultrasound; X-ray
Therapeutic target: Growth hormone replacement (other); Growth hormone replacement (pediatric)
Development phase: Early Stage; Preclinical; Phase I; Phase I/II; Phase II; Phase III; Phase III/IV; Preregistration; Registered

Clients in focus...

Get the Flash Player to see this rotator.

Press releases: Innovaro Pharmalicensing current industry press releases.